Extrawell Pharmaceutical Holdings Limited Profile Avatar - Palmy Investing

Extrawell Pharmaceutical Holdings Limited

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Dev…

Drug Manufacturers - Specialty & Generic
HK, Quarry Bay [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
27.43 26.17 30.15 30.91 26.65 39.63 48.74 40.68 49.03 55.59 55.32 54.02 50.80 42.91 48.70
Profit Margin
7.45 5.82 12.97 7.20 10.42 438.91 19.27 19.27 34.90 71.77 107.34 -153.67 176.65 178.11 -275.73
Operating Margin
6.51 2.57 5.39 7.92 25.08 -37.42 0.34 -13.91 -20.08 -19.02 -21.05 -8.86 -24.97 -15.37 -13.81
EPS Growth
-5.88 -20.31 74.51 -24.72 -11.94 3,967.80 -94.29 -36.50 4.60 114.29 78.46 -245.69 207.69 -0.92 -226.06
Return on Assets (ROA)
2.24 1.74 2.97 1.52 2.18 49.66 2.36 1.77 2.46 5.35 6.58 -10.40 9.91 8.95 -12.66
Return on Equity (ROE)
4.34 3.27 5.47 2.83 4.78 57.01 2.69 2.02 2.79 6.00 13.22 -23.37 19.99 16.80 -14.64
Return on Invested Capital (ROIC)
4.62 1.14 2.12 2.70 4.38 -4.75 0.05 -1.36 -1.54 -1.52 -1.36 -0.66 -1.46 -0.80 -0.67
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - - - 0.70 3.30 17.85 2.19 2.56 3.00 3.43 4.15 45.27 50.17 45.37 42.38 9.21
Debt/Equity
- - - - 1.29 6.17 39.17 2.52 2.92 3.42 3.89 4.65 90.93 112.73 91.48 79.58 10.65
Debt/EBITDA
-437.21 -830.19 -1,234.47 -1,039.70 -355.59 -793.35 5,324.94 -3,869.73 -3,623.32 -3,869.35 -4,276.39 40,540.28 -4,722.64 -19,822.38 791.48
Debt/Capitalization
- - - - 1.27 5.81 28.15 2.46 2.83 3.30 3.75 4.45 47.63 52.99 47.77 44.32 9.62
Interest Debt per Share HKD
- - - - - - 0.01 0.05 0.01 0.01 0.01 0.01 0.02 0.24 0.25 0.26 0.26 0.06
Debt Growth
- - - - - - -100.00 - - -80.57 2,069.68 1.02 1.20 1.41 2.65 1.62 1.95 3.00 -80.44
Liquidity
Current Ratio
328.09 355.26 425.65 418.21 200.69 216.43 239.10 266.29 209.77 261.66 358.46 364.61 303.42 313.37 345.41
Quick Ratio
302.27 336.66 408.14 400.31 192.78 201.88 233.96 259.30 205.82 254.36 343.92 350.42 283.71 306.48 331.26
Cash Ratio
117.26 177.50 215.47 185.68 91.13 129.91 157.14 200.20 155.89 186.74 253.60 256.33 208.57 214.34 222.82
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
616.09 963.66 847.02 793.72 1,197.96 456.16 1,230.39 841.42 1,066.17 680.25 408.82 441.15 287.91 1,055.91 417.33
Receivables Turnover
- - - - - - 201.95 216.63 154.07 249.39 288.38 406.92 445.04 157.19 154.10 167.66 152.82 113.42
Payables Turnover
1,680.00 2,052.36 1,044.39 317.42 108.67 98.69 657.06 430.76 632.06 487.61 555.67 541.48 563.34 624.57 651.04
Asset Turnover
30.00 29.94 22.89 21.05 20.92 11.31 12.25 9.20 7.05 7.46 6.13 6.77 5.61 5.02 4.59
Coverage
Interest Coverage
- - - - - - - - 548.22 -1,224.17 10.37 -270.32 -261.26 -216.95 -174.72 -62.13 -139.53 -71.34 -43.41
Asset Coverage
- - - - 6,800 - - 200 4,000 100 100 200 100 200 100 200 200 1,000
Cash Flow Coverage (CFGR)
- - - - 197.13 43.94 64.02 -94.02 21.15 15.59 -11.71 -30.40 -1.79 -0.04 -0.27 0.52 -3.11
EBITDA Coverage
- - - - - - - - - - 400 100 -100 -100 -100 -100 - - - - - - - -
Dividend Coverage
-1,100 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 - - - - - - - - - - 400 - - - - - - - - - -
Market Prospects
Dividend Yield
0.04 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
0.48 0.68 2.07 0.71 1.26 73.98 2.97 2.55 5.08 18.36 38.72 -32.48 62.80 80.73 -235.10
Price/Earnings (P/E)
208.2672 146.5030 48.2365 141.0721 79.5056 1.3517 33.6204 39.2345 19.6762 5.4465 2.5829 -3.0788 1.5923 1.2388 -0.4253
Price/Book (P/B)
904.32 478.49 263.69 399.20 380.22 77.06 90.56 79.24 54.96 32.69 34.14 71.96 31.83 20.81 6.23
Price/Sales (P/S)
1,551.62 852.35 625.58 1,015.64 828.44 593.27 647.82 756.16 686.68 390.89 277.25 473.14 281.27 220.63 117.28
Price/Cash Flow (P/CF)
9,710.51 9,075.14 10,391.52 14,733.05 1,516.14 -3,254.28 14,682.82 14,883.62 -12,060.41 -2,311.22 -2,096.90 -160,706.90 -13,003.75 4,982.27 -1,878.83
End of 0858.HK's Analysis
CIK: - CUSIP: - ISIN: BMG3285Q1134 LEI: - UEI: -
Secondary Listings
0858.HK has no secondary listings inside our databases.